WebDr. Mary Lou Affronti is a Professor who joined the Duke University School of Nursing faculty in February 2014. She earned both her DNP and her MSN at DUSON, and … Web2009. Interstitial chemotherapy with biodegradable BCNU (Gliadel ®) wafers in the treatment of malignant gliomas. DA Bota, A Desjardins, JA Quinn, ML Affronti, HS Friedman. …
Mary Lou Affronti - Google Scholar
Web“Dr. Cone is an advocate for interdisciplinary advanced practice providers (APPs) to practice to the extent of their licensure and education,” commented Mary Lou Affronti, DNP, RN, MHSc, ANP, Brain Tumor Center Adult Clinical Director, Brain Tumor Center Nurse Practitioner/Primary Investigator, and Associate Professor at the Duke School of Nursing. Web9 de jun. de 2009 · Free Access Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy Mary Lou Affronti RN, MSN, ANP, Christopher R. Heery MD, James E. Herndon II PhD, Jeremy N. Rich MD, David A. Reardon MD, … the wessington brewers fayre
Mary Lou Affronti Nexus Summit 2024
WebView Mary Lou Affronti’s professional profile on LinkedIn. LinkedIn is the world’s largest business network, helping professionals like Mary Lou Affronti discover inside … WebMary Lou Affronti, James E. Herndon, Mallika P Patel> ;Supportive Care in Cancer. 2024 Sep 3 6 citations Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of … Web6 de jun. de 2016 · Mary Lou Affronti, Sarah Woodring & Henry S. Friedman. Duke University School of Nursing, Durham, NC, 27710, USA. Mary Lou Affronti. The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Room 047 Baker House, South Hospital, Trent Drive, Durham, NC, 27710, USA. the wessex rose hotel boat